menu
    • menu

    Company profile for iTolerance

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    iTolerance is an early-stage privately held regenerative medicine company developing technologies to enable tissue, organoid or cell therapy without the need for life-long immunosuppression. Leveraging its proprietary biotechnology-derived Strepavidin-FasL fusion protein/biotin-PEG microgel (SA-FasL microgel) platform technology, iTOL-100, iTolerance is advancing a pipeline of programs using both allogenic pancreatic islets an...
    iTolerance is an early-stage privately held regenerative medicine company developing technologies to enable tissue, organoid or cell therapy without the need for life-long immunosuppression. Leveraging its proprietary biotechnology-derived Strepavidin-FasL fusion protein/biotin-PEG microgel (SA-FasL microgel) platform technology, iTOL-100, iTolerance is advancing a pipeline of programs using both allogenic pancreatic islets and stem cells that have the potential to cure diseases. The Company’s lead program, iTOL-101 is being developed for Type 1 Diabetes and in a pre-clinical non-human primate study, pancreatic islet cells co-implanted.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    iToleranceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1951 NW 7th Ave. Suite 300 Miami, FL. 33136
    Telephone
    Telephone
    833-475-8247
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://itolerance.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ITolerance's Anthony Wins BioFlorida R&D Award of the Year
    ITolerance's Anthony Wins BioFlorida R&D Award of the Year

    12 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-12/itolerance-ceo-anthony-japour-receives-biofloridas-research-developer-of-the-year-award

    PHARMIWEB
    12 Nov 2025
    Share Share
    Itolerance Launches Patient Journey Series On Type 1 Diabetes
    Itolerance Launches Patient Journey Series On Type 1 Diabetes

    09 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-09/itolerance-inc-launches-patient-journey-series-highlighting-the-real-life-impact-of-type-1-diabete

    PHARMIWEB
    09 Oct 2025
    Share Share
    Itolerance Appoints Sandra Cohen Kalter To Strategic Advisory
    Itolerance Appoints Sandra Cohen Kalter To Strategic Advisory

    22 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-22/itolerance-inc-appoints-sandra-cohen-kalter-to-strategic-advisory-group

    PHARMAWEB
    22 Sep 2025
    Share Share
    iTolerance Names Ex-FDA Biochemistry Chief Emily Shacter to Board
    iTolerance Names Ex-FDA Biochemistry Chief Emily Shacter to Board

    21 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-21/itolerance-inc-appoints-former-chief-of-the-laboratory-of-biochemistry-in-the-fdas-center-for-dru

    PHARMAWEB
    21 Aug 2025
    Share Share
    iTolerance Joins Virtual Investor 'What’s Your Story' Conference
    iTolerance Joins Virtual Investor 'What’s Your Story' Conference

    22 Jul 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/itolerance-inc.-participates-in-the-virtual-investor-%22what%e2%80%99s-your-sto-1051148

    ACCESSWIRE
    22 Jul 2025
    Share Share
    NLS Pharma Notes Progress in iTOL-102 Type 1 Diabetes Study
    NLS Pharma Notes Progress in iTOL-102 Type 1 Diabetes Study

    17 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nls-pharmaceutics-highlights-continued-progress-in-itol-102-diabetes-program-as-bird-foundation-approves-additional-milestone-payment-to-kadimastem-and-itolerance-for-continued-co-development-of-type-1-diabetes-cell-therapy-302507798.html

    PR NEWSWIRE
    17 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search